{
  "ticker": "CYTK",
  "company_name": "Cytokinetics, Incorporated",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03767855",
      "title": "A Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Symptomatic Obstructive Hypertrophic Cardiomyopathy, Healthy Subjects",
      "start_date": "2018-12-04",
      "completion_date": "2020-01-03",
      "enrollment": 0,
      "sponsor": "Cytokinetics"
    },
    {
      "nct_id": "NCT01486849",
      "title": "Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Amyotrophic Lateral Sclerosis",
      "start_date": "2011-11",
      "completion_date": "2012-03",
      "enrollment": 0,
      "sponsor": "Cytokinetics"
    },
    {
      "nct_id": "NCT00748579",
      "title": "Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Heart Failure",
      "start_date": "2008-09",
      "completion_date": "2009-07",
      "enrollment": 0,
      "sponsor": "Cytokinetics"
    },
    {
      "nct_id": "NCT01077167",
      "title": "Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients",
      "status": "WITHDRAWN",
      "phase": "PHASE2",
      "condition": "Heart Failure",
      "start_date": "2010-07",
      "completion_date": "2011-05",
      "enrollment": 0,
      "sponsor": "Cytokinetics"
    },
    {
      "nct_id": "NCT04464525",
      "title": "Omecamtiv Mecarbil Post-trial Access Study",
      "status": "WITHDRAWN",
      "phase": "PHASE3",
      "condition": "Chronic Heart Failure With Reduced Ejection Fraction",
      "start_date": "2020-12-18",
      "completion_date": "2026-11-27",
      "enrollment": 0,
      "sponsor": "Cytokinetics"
    },
    {
      "nct_id": "NCT01380223",
      "title": "A Pharmacokinetic and Pharmacodynamic Study of Omecamtiv Mecarbil in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Heart Failure",
      "start_date": "2005-08",
      "completion_date": "2006-04",
      "enrollment": 0,
      "sponsor": "Cytokinetics"
    },
    {
      "nct_id": "NCT04944784",
      "title": "A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Amyotrophic Lateral Sclerosis",
      "start_date": "2021-08-16",
      "completion_date": "2023-07-18",
      "enrollment": 0,
      "sponsor": "Cytokinetics"
    },
    {
      "nct_id": "NCT04848506",
      "title": "Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM",
      "status": "ENROLLING_BY_INVITATION",
      "phase": "PHASE2, PHASE3",
      "condition": "Symptomatic Hypertrophic Cardiomyopathy (HCM)",
      "start_date": "2021-05-06",
      "completion_date": "2028-03",
      "enrollment": 0,
      "sponsor": "Cytokinetics"
    },
    {
      "nct_id": "NCT03759392",
      "title": "Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Heart Failure With Reduced Ejection Fraction",
      "start_date": "2019-04-09",
      "completion_date": "2022-01-06",
      "enrollment": 0,
      "sponsor": "Cytokinetics"
    },
    {
      "nct_id": "NCT04175808",
      "title": "Study to Assess the Effect of Omecamtiv Mecarbil (OM) on QT/QTc Intervals in Healthy Adults",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "QT Intervals Changes, QTc Intervals Changes",
      "start_date": "2019-11-14",
      "completion_date": "2020-03-04",
      "enrollment": 0,
      "sponsor": "Cytokinetics"
    }
  ],
  "summary": {
    "total_trials": 45,
    "by_phase": {
      "PHASE1": 11,
      "PHASE2": 19,
      "PHASE3": 11,
      "PHASE2, PHASE3": 2,
      "": 1,
      "PHASE1, PHASE2": 1
    },
    "by_status": {
      "COMPLETED": 30,
      "TERMINATED": 7,
      "WITHDRAWN": 2,
      "ENROLLING_BY_INVITATION": 1,
      "NOT_YET_RECRUITING": 1,
      "RECRUITING": 3,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 5,
    "completed_trials": 30,
    "conditions": [
      "Amyotrophic Lateral Sclerosis",
      "Amyotrophic Lateral Sclerosis (ALS)",
      "Breast Neoplasms",
      "Chronic Heart Failure With Reduced Ejection Fraction",
      "Chronic Obstructive Pulmonary Disease (COPD)",
      "Healthy Participants",
      "Healthy Volunteer",
      "Heart Failure",
      "Heart Failure With Reduced Ejection Fraction",
      "Heart Failure, Heart Failure With Reduced Ejection Fraction",
      "Heart Failure, Myocardial Ischemia, Angina Pectoris",
      "Hypertrophic Cardiomyopathy (HCM)",
      "Intermittent Claudication, Peripheral Artery Disease",
      "Mobility Limitation",
      "Modified Release Oral Formulation, Left Ventricular Systolic Dysfunction, Chronic Heart Failure, History of Chronic Heart Failure, Left Ventricular Ejection Fraction, Pharmacokinetics, Echocardiogram",
      "Myasthenia Gravis",
      "Non-Hodgkin's Lymphoma, Hodgkin's Disease",
      "Obstructive Hypertrophic Cardiomyopathy (oHCM)",
      "Obstructive Hypertrophic Cardiomyopathy, Healthy Adult Subjects",
      "Pediatric, Symptomatic Obstructive Hypertrophic Cardiomyopathy",
      "QT Intervals Changes, QTc Intervals Changes",
      "Spinal Muscular Atrophy",
      "Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF)",
      "Symptomatic Hypertrophic Cardiomyopathy (HCM)",
      "Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy",
      "Symptomatic Obstructive Hypertrophic Cardiomyopathy, Healthy Subjects"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:17:54.975344",
    "search_query": "Cytokinetics, Incorporated",
    "url": "https://clinicaltrials.gov/search?term=Cytokinetics,+Incorporated"
  }
}